These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31883091)

  • 21. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.
    Okba NMA; Raj VS; Widjaja I; GeurtsvanKessel CH; de Bruin E; Chandler FD; Park WB; Kim NJ; Farag EABA; Al-Hajri M; Bosch BJ; Oh MD; Koopmans MPG; Reusken CBEM; Haagmans BL
    Emerg Infect Dis; 2019 Oct; 25(10):1868-1877. PubMed ID: 31423970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of serological assays available in a biosafety level 2 laboratory and their application for survey of Middle East respiratory syndrome coronavirus among livestock in Ethiopia.
    Teramichi T; Fukushi S; Hachiya Y; Melaku SK; Oguma K; Sentsui H
    J Vet Med Sci; 2019 Dec; 81(12):1887-1891. PubMed ID: 31685722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of different indirect ELISAs for MERS-CoV serological testing.
    Hashem AM; Al-Amri SS; Al-Subhi TL; Siddiq LA; Hassan AM; Alawi MM; Alhabbab RY; Hindawi SI; Mohammed OB; Amor NS; Alagaili AN; Mirza AA; Azhar EI
    J Immunol Methods; 2019 Mar; 466():41-46. PubMed ID: 30659836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016.
    Ali M; El-Shesheny R; Kandeil A; Shehata M; Elsokary B; Gomaa M; Hassan N; El Sayed A; El-Taweel A; Sobhy H; Fasina FO; Dauphin G; El Masry I; Wolde AW; Daszak P; Miller M; VonDobschuetz S; Morzaria S; Lubroth J; Makonnen YJ
    Euro Surveill; 2017 Mar; 22(11):. PubMed ID: 28333616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus.
    Crameri G; Durr PA; Klein R; Foord A; Yu M; Riddell S; Haining J; Johnson D; Hemida MG; Barr J; Peiris M; Middleton D; Wang LF
    Emerg Infect Dis; 2016 Jun; 22(6):1071-4. PubMed ID: 27070733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013.
    Perera RA; Wang P; Gomaa MR; El-Shesheny R; Kandeil A; Bagato O; Siu LY; Shehata MM; Kayed AS; Moatasim Y; Li M; Poon LL; Guan Y; Webby RJ; Ali MA; Peiris JS; Kayali G
    Euro Surveill; 2013 Sep; 18(36):pii=20574. PubMed ID: 24079378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.
    Arabi YM; Hajeer AH; Luke T; Raviprakash K; Balkhy H; Johani S; Al-Dawood A; Al-Qahtani S; Al-Omari A; Al-Hameed F; Hayden FG; Fowler R; Bouchama A; Shindo N; Al-Khairy K; Carson G; Taha Y; Sadat M; Alahmadi M
    Emerg Infect Dis; 2016 Sep; 22(9):1554-61. PubMed ID: 27532807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
    Houser KV; Broadbent AJ; Gretebeck L; Vogel L; Lamirande EW; Sutton T; Bock KW; Minai M; Orandle M; Moore IN; Subbarao K
    PLoS Pathog; 2017 Aug; 13(8):e1006565. PubMed ID: 28817732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of candidate vaccine approaches for MERS-CoV.
    Wang L; Shi W; Joyce MG; Modjarrad K; Zhang Y; Leung K; Lees CR; Zhou T; Yassine HM; Kanekiyo M; Yang ZY; Chen X; Becker MM; Freeman M; Vogel L; Johnson JC; Olinger G; Todd JP; Bagci U; Solomon J; Mollura DJ; Hensley L; Jahrling P; Denison MR; Rao SS; Subbarao K; Kwong PD; Mascola JR; Kong WP; Graham BS
    Nat Commun; 2015 Jul; 6():7712. PubMed ID: 26218507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
    Han HJ; Liu JW; Yu H; Yu XJ
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30513619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
    Coleman CM; Venkataraman T; Liu YV; Glenn GM; Smith GE; Flyer DC; Frieman MB
    Vaccine; 2017 Mar; 35(12):1586-1589. PubMed ID: 28237499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Kotani O; Sato H; Sekimukai H; Fukushi S; Suzuki T; Sato Y; Takeda M; Tashiro M; Hasegawa H; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for a MERS-CoV spike vaccine.
    Zhou Y; Jiang S; Du L
    Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
    Rodon J; Okba NMA; Te N; van Dieren B; Bosch BJ; Bensaid A; Segalés J; Haagmans BL; Vergara-Alert J
    Emerg Microbes Infect; 2019; 8(1):1593-1603. PubMed ID: 31711379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013.
    Reusken CB; Ababneh M; Raj VS; Meyer B; Eljarah A; Abutarbush S; Godeke GJ; Bestebroer TM; Zutt I; Muller MA; Bosch BJ; Rottier PJ; Osterhaus AD; Drosten C; Haagmans BL; Koopmans MP
    Euro Surveill; 2013 Dec; 18(50):20662. PubMed ID: 24342516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East.
    Kandeil A; Gomaa M; Nageh A; Shehata MM; Kayed AE; Sabir JSM; Abiadh A; Jrijer J; Amr Z; Said MA; Byarugaba DK; Wabwire-Mangen F; Tugume T; Mohamed NS; Attar R; Hassan SM; Linjawi SA; Moatassim Y; Kutkat O; Mahmoud S; Bagato O; Shama NMA; El-Shesheny R; Mostafa A; Perera RA; Chu DK; Hassan N; Elsokary B; Saad A; Sobhy H; El Masry I; McKenzie PP; Webby RJ; Peiris M; Makonnen YJ; Ali MA; Kayali G
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31387326
    [No Abstract]   [Full Text] [Related]  

  • 37. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
    Luke T; Wu H; Zhao J; Channappanavar R; Coleman CM; Jiao JA; Matsushita H; Liu Y; Postnikova EN; Ork BL; Glenn G; Flyer D; Defang G; Raviprakash K; Kochel T; Wang J; Nie W; Smith G; Hensley LE; Olinger GG; Kuhn JH; Holbrook MR; Johnson RF; Perlman S; Sullivan E; Frieman MB
    Sci Transl Med; 2016 Feb; 8(326):326ra21. PubMed ID: 26888429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing the MERS coronavirus threat.
    Haagmans BL; Osterhaus AD
    Sci Transl Med; 2014 May; 6(235):235fs19. PubMed ID: 24807556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light.
    Hindawi SI; Hashem AM; Damanhouri GA; El-Kafrawy SA; Tolah AM; Hassan AM; Azhar EI
    Transfusion; 2018 Jan; 58(1):52-59. PubMed ID: 29239484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
    Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
    Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.